|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4A
|
|
pubmed:dateCreated |
1996-9-10
|
|
pubmed:abstractText |
Predicting the outcome of patients with colorectal adenocarcinoma (CRCA) prior to surgery would be valuable in selecting high-risk individuals who may benefit from pre-operative adjuvant therapy. The aim of this study is to determine whether the expression of TGF-alpha in preoperative biopsies of patients with CRCA constitutes a significant prognostic indicator.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1999-2003
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8712733-Actuarial Analysis,
pubmed-meshheading:8712733-Adenocarcinoma,
pubmed-meshheading:8712733-Antibodies, Monoclonal,
pubmed-meshheading:8712733-Biopsy,
pubmed-meshheading:8712733-Colorectal Neoplasms,
pubmed-meshheading:8712733-Follow-Up Studies,
pubmed-meshheading:8712733-Humans,
pubmed-meshheading:8712733-Immunoenzyme Techniques,
pubmed-meshheading:8712733-Immunohistochemistry,
pubmed-meshheading:8712733-Predictive Value of Tests,
pubmed-meshheading:8712733-Prognosis,
pubmed-meshheading:8712733-Survival Analysis,
pubmed-meshheading:8712733-Transforming Growth Factor alpha
|
|
pubmed:articleTitle |
Transforming growth factor alpha (TGF-alpha) expression in biopsies of colorectal carcinoma is a significant prognostic indicator.
|
|
pubmed:affiliation |
Department of Pathology, Baylor College of Medicine, Houston, TX 77030, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
